Built-for-Purpose Offering Delivers High-Confidence Results for Biomolecule Attribute Monitoring

Built-for-Purpose Offering Delivers High-Confidence Results for Biomolecule Attribute Monitoring The Thermo Scientific Orbitrap Exploris MX enables customer success by combining high-quality data with operational simplicity PHILADELPHIA, Nov. 1, 2021 /PRNewswire/ — ASMS 2021 – Biopharmaceutical laboratories can now benefit from high-quality mass information delivered by Orbitrap technology for molecule attribute monitoring in development and quality control... Read more

End-to-End Multi-Attribute Method Solution Accelerates Biotherapeutic Development and Manufacturing

End-to-End Multi-Attribute Method Solution Accelerates Biotherapeutic Development and Manufacturing The Thermo Scientific MAM 2.0 workflow delivers reproducible, transferable and high-confidence results, while reducing costs and improving efficiency PHILADELPHIA, Nov. 1, 2021 /PRNewswire/ — ASMS 2021 – Biopharmaceutical laboratories working across R&D, manufacturing and quality control (QC) environments can now streamline biopharmaceutical characterization, process monitoring and release testing... Read more

Innovative Approach Redefines Data Analysis in Proteomics Research

Thermo Fisher Scientific and MSAID continue their collaboration to deliver transformative deep learning tools for proteomics data analysis PHILADELPHIA, Nov. 1, 2021 /PRNewswire/ — ASMS 2021 – Thermo Fisher Scientific, the world leader in serving science, and MSAID, the leader in proteomics artificial intelligence, have collaborated to provide proteomics researchers with advanced mass spectrometry software that generates... Read more

Updated Software Solutions Enable New Insights and Productivity

Thermo Scientific software suite improvements deliver enhanced performance, usability and integration across a wide range of workflows PHILADELPHIA, Nov. 1, 2021 /PRNewswire/ — ASMS 2021 – Scientists in proteomics, biopharmaceutical, pharmaceutical, forensics, environmental, food safety, clinical, metabolomics and lipidomics settings can now benefit from the newest software releases with streamlined workflows to deliver more comprehensive analysis... Read more

PerkinElmer Releases 2021 Corporate Social Responsibility Report

Report highlights stewardship and sustainability progress and solidifies new ESG commitments WALTHAM, Mass.–(BUSINESS WIRE)–Nov. 1, 2021– PerkinElmer, Inc. (NYSE: PKI), a global leader innovating for a healthier world, today released its 2021 Corporate Social Responsibility (CSR) Report, which summarizes the latest achievements of its environmental, social and governance (ESG) program. The report titled, “Strengthening Our... Read more

Understanding Drug Resistant Cervical Cancer Cells

Dr. Pontsho Moela, a researcher and lecturer at the University of Pretoria (South Africa), caught our attention with her Tweet showing her excitement at the installation of a new ZEISS Primovert microscope by her local ZEISS representative which will be used for cancer cell visualization. We contacted her to find out more about her research... Read more

#WorldStrokeDay: GE Healthcare & Circle Neurovascular Imaging Announce A New Collaboration To Enhance Acute Stroke Care with #AI

Chicago, October 29, 2021: Today – World Stroke Day – GE Healthcare is proud to announce its collaboration with Circle Neurovascular Imaging (Circle NVI) to provide health systems with innovative and clinically validated AI-powered solutions to enhance acute stroke care. GE Healthcare’s expanded FastStroke processing platform, including AI-based tools from Circle NVI, will help frontline... Read more

#WorldStrokeDay: GE Healthcare & Circle Neurovascular Imaging Announce A New Collaboration To Enhance Acute Stroke Care with #AI

Chicago, October 29, 2021: Today – World Stroke Day – GE Healthcare is proud to announce its collaboration with Circle Neurovascular Imaging (Circle NVI) to provide health systems with innovative and clinically validated AI-powered solutions to enhance acute stroke care. GE Healthcare’s expanded FastStroke processing platform, including AI-based tools from Circle NVI, will help frontline... Read more

IMPACT trial data shows clear benefit in using Roche's CINtec PLUS Cytology test for women who are at higher risk of developing cervical cancer

IMPACT trial data shows clear benefit in using Roche’s CINtec PLUS Cytology test for women who are at higher risk of developing cervical cancer Every year, over 604,000 women worldwide are diagnosed with cervical cancer and approximately 342,000 die from this preventable disease, caused by Infection with high-risk human papillomavirus (HPV). As recently published in... Read more